1. A Case of Lung Cancer with Peritoneal Carcinomatosis Effectively Treated with Docetaxel
   Kenji Morimoto et al, 2019, Haigan CrossRef
2. ROS1-rearranged lung adenocarcinoma with peritoneal carcinomatosis on initial presentation
   Vera Kazakova et al, 2020, BMJ Case Reports CrossRef
3. Epidemiology: Extent of the Problem
   Simone Sibio et al, 2015, Treatment of Peritoneal Surface Malignancies CrossRef
4. Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer
   Yonghui Wang et al, 2022, Nanoscale CrossRef
5. Therapeutic Strategies and Oncological Outcome of Peritoneal Metastases from Lung Cancer: A Systematic Review and Pooled Analysis
   Leandro Siragusa et al, 2023, Current Oncology CrossRef
6. Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549/DDP xenograft tumors
   Chao Liu et al, 2018, Oncology Letters CrossRef
7. Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma
   Hussein Nassereddine et al, 2020, Pathology & Oncology Research CrossRef
8. Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status
   Tejas Patil et al, 2016, Lung Cancer CrossRef
9. Flourine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of Peritoneal Carcinomatosis in Lung Cancer: A Case Study
   Tshimogo Sathekge et al, 2024, World Journal of Nuclear Medicine CrossRef
10. Reactive Oxygen Species (ROS)-Responsive Charge-Switchable Nanocarriers for Gene Therapy of Metastatic Cancer
    Jiajia Xiang et al, 2018, ACS Applied Materials & Interfaces CrossRef
11. Features of lymph node metastasis depending on intratumoral heterogeneity of non-small cell lung cancer in patients with different morphological changes in the bronchial epithelium
    M. V. Zavyalova et al, 2022, Siberian journal of oncology CrossRef
12. Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer: Retrospective Multicentric Analysis and Literature Review
    Maria Ida Abbate et al, 2019, Future Oncology CrossRef
13. Immune response and locoregional treatments for peritoneal carcinomatosis
    Caterina Fiorentini et al, 2022, Cellular Immunity in the Peritoneum CrossRef
14. Peritoneum as the sole distant metastatic site of lung adenosquamous cell carcinoma: a case report
    Pan Yang et al, 2017, Journal of Medical Case Reports CrossRef
15. Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: A case report and literature review
    Ji-Xin Fu et al, 2022, Medicine CrossRef
16. Gastric Metastasis From Lung Adenocarcinoma: An Uncommon Presentation
    Ana Neves et al, 2023, Cureus CrossRef
17. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells
    YANYAN GAO et al, 2015, Molecular Medicine Reports CrossRef
18. Autophagy-inhibiting polymer as an effective nonviral cancer gene therapy vector with inherent apoptosis-sensitizing ability
    Jiafeng Wang et al, 2020, Biomaterials CrossRef
19. An Unusual Case of Isolated Peritoneal Metastases from Lung Adenocarcinoma
    Aziz Bazine et al, 2014, Case Reports in Oncology CrossRef
20. Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung
    Jui‐Feng Hsu et al, 2019, Asia-Pacific Journal of Clinical Oncology CrossRef
21. Diagnostic value of ascites immunohistochemistry in carcinomatosis of unknown origin
    María Marco Gómez et al, 2024, Revista Española de Enfermedades Digestivas CrossRef
22. Peritoneal metastases from extra-abdominal cancer – A population-based study
    M. Flanagan et al, 2018, European Journal of Surgical Oncology CrossRef
23. Krukenberg Tumor in Association with Ureteral Stenosis Due to Peritoneal Carcinomatosis from Pulmonary Adenocarcinoma: A Case Report
    Irina Balescu et al, 2020, Medicina CrossRef